the role of bispecific antibodies in the treatment landscape for r/r dlbcl
Published 2 months ago • 118 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
1:54
the important role of bispecific antibodies in the future treatment of r/r dlbcl
-
1:15
the role of bispecific antibodies in the treatment of r/r large b-cell lymphoma
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
1:56
the future of bispecific antibodies in the treatment and management of r/r follicular lymphoma
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
4:02
an overview of bispecifics in r/r myeloma and their integration into the treatment landscape
-
1:48
the potential of bispecific antibody-containing combinations in patients with b-cell lymphomas
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
1:03:31
ind enabling cmc strategies for bispecific antibodies
-
10:08
nsw health statewide biobank b roll
-
5:30
my journey to clinical trial of lenalidomide & mosunetuzumab for follicular lymphoma day 1
-
1:17
the promise of bispecific antibodies in the treatment of nhl
-
3:12
the role of bispecific antibodies in r/r nhl: the biology of these agents and what the future holds
-
2:25
advancements and challenges in bispecific antibodies for the treatment of b-nhl
-
2:22
outcomes and management of patients with r/r myeloma who progress on bispecific antibodies
-
2:38
approaching the treatment of patients with lbcl who relapse after bispecific antibodies
-
2:17
the role of car t-cell therapy for treating myeloma in the era of bispecific antibodies
-
1:21
cd20/cd3 bispecific antibodies in r/r dlbcl: glofitamab and epcoritamab
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
2:00
the success story of bispecific and trispecific antibodies
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial